Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1976 1
1986 2
1992 1
1996 1
1999 2
2000 1
2001 2
2006 1
2007 3
2009 1
2010 1
2012 1
2013 1
2014 4
2015 4
2016 6
2017 6
2018 9
2019 11
2020 13
2021 43
2022 16
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kw lee (797 results)?
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, Li S, Sahu S, Liu Y, Ban Y, Guidry K, Hu H, Lopez A, Sherman F, Tan YJ, Lee YT, Armstrong AP, Dolgalev I, Sahu P, Zhang T, Lu W, Gray NS, Christensen JG, Tang TT, Velcheti V, Khodadadi-Jamayran A, Wong KK, Neel BG. Mukhopadhyay S, et al. Cancer Res. 2023 Dec 15;83(24):4095-4111. doi: 10.1158/0008-5472.CAN-23-2729. Cancer Res. 2023. PMID: 37729426
SIGNIFICANCE: Identification of synthetic lethal genes with KRASG12C using genome-wide CRISPR/Cas9 screening and credentialing of the ability of TEAD inhibition to enhance KRASG12C efficacy provides a roadmap for combination strategies. See related commentary by Johnson an …
SIGNIFICANCE: Identification of synthetic lethal genes with KRASG12C using genome-wide CRISPR/Cas9 screening and credentialing of the abilit …
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma.
Sahin U, Türeci Ö, Manikhas G, Lordick F, Rusyn A, Vynnychenko I, Dudov A, Bazin I, Bondarenko I, Melichar B, Dhaene K, Wiechen K, Huber C, Maurus D, Arozullah A, Park JW, Schuler M, Al-Batran SE. Sahin U, et al. Ann Oncol. 2021 May;32(5):609-619. doi: 10.1016/j.annonc.2021.02.005. Epub 2021 Feb 19. Ann Oncol. 2021. PMID: 33610734 Free article. Clinical Trial.
Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses.
Chan YK, Wang SK, Chu CJ, Copland DA, Letizia AJ, Costa Verdera H, Chiang JJ, Sethi M, Wang MK, Neidermyer WJ Jr, Chan Y, Lim ET, Graveline AR, Sanchez M, Boyd RF, Vihtelic TS, Inciong RGCO, Slain JM, Alphonse PJ, Xue Y, Robinson-McCarthy LR, Tam JM, Jabbar MH, Sahu B, Adeniran JF, Muhuri M, Tai PWL, Xie J, Krause TB, Vernet A, Pezone M, Xiao R, Liu T, Wang W, Kaplan HJ, Gao G, Dick AD, Mingozzi F, McCall MA, Cepko CL, Church GM. Chan YK, et al. Sci Transl Med. 2021 Feb 10;13(580):eabd3438. doi: 10.1126/scitranslmed.abd3438. Sci Transl Med. 2021. PMID: 33568518 Free PMC article.
MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
Zhang M, Wong SW, Wright JN, Wagner MW, Toescu S, Han M, Tam LT, Zhou Q, Ahmadian SS, Shpanskaya K, Lummus S, Lai H, Eghbal A, Radmanesh A, Nemelka J, Harward S 2nd, Malinzak M, Laughlin S, Perreault S, Braun KRM, Lober RM, Cho YJ, Ertl-Wagner B, Ho CY, Mankad K, Vogel H, Cheshier SH, Jacques TS, Aquilina K, Fisher PG, Taylor M, Poussaint T, Vitanza NA, Grant GA, Pfister S, Thompson E, Jaju A, Ramaswamy V, Yeom KW. Zhang M, et al. Radiology. 2022 Aug;304(2):406-416. doi: 10.1148/radiol.212137. Epub 2022 Apr 19. Radiology. 2022. PMID: 35438562 Free PMC article.
RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Chaudhary and Bapuraj in this issue....
RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Chaudhary and Bapuraj in this issue. …
CT-based Radiogenomic Analysis of Clinical Stage I Lung Adenocarcinoma with Histopathologic Features and Oncologic Outcomes.
Perez-Johnston R, Araujo-Filho JA, Connolly JG, Caso R, Whiting K, Tan KS, Zhou J, Gibbs P, Rekhtman N, Ginsberg MS, Jones DR. Perez-Johnston R, et al. Radiology. 2022 Jun;303(3):664-672. doi: 10.1148/radiol.211582. Epub 2022 Mar 1. Radiology. 2022. PMID: 35230187 Free PMC article.
RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Nishino in this issue....
RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Nishino in this issue....
Cardiac MRI to Predict Sudden Cardiac Death Risk in Dilated Cardiomyopathy.
Li Y, Xu Y, Li W, Guo J, Wan K, Wang J, Xu Z, Han Y, Sun J, Chen Y. Li Y, et al. Radiology. 2023 May;307(3):e222552. doi: 10.1148/radiol.222552. Epub 2023 Mar 14. Radiology. 2023. PMID: 36916890 Clinical Trial.
ChiCTR1800017058 RSNA, 2023 Supplemental material is available for this article. See also the editorial by Sakuma in this issue....
ChiCTR1800017058 RSNA, 2023 Supplemental material is available for this article. See also the editorial by Sakuma in this issue....
Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
Zheng K, Zhu X, Fu S, Cao G, Li WQ, Xu L, Chen H, Wu D, Yang R, Wang K, Liu W, Wang H, Bao Q, Liu M, Hao C, Shen L, Xing B, Wang X. Zheng K, et al. Radiology. 2022 May;303(2):455-464. doi: 10.1148/radiol.211545. Epub 2022 Feb 1. Radiology. 2022. PMID: 35103539 Clinical Trial.
NCT03009461 RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Chung in this issue....
NCT03009461 RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Chung in this issue....
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group. Matsuoka K, et al. Lancet Gastroenterol Hepatol. 2022 Jul;7(7):648-657. doi: 10.1016/S2468-1253(22)00022-X. Epub 2022 Mar 30. Lancet Gastroenterol Hepatol. 2022. PMID: 35366419 Clinical Trial.
FUNDING: EA Pharma and Kissei Pharmaceutical. TRANSLATION: For the Japanese translation of the abstract see Supplementary Materials section....
FUNDING: EA Pharma and Kissei Pharmaceutical. TRANSLATION: For the Japanese translation of the abstract see Supplementary Materials s …
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice.
Yura Y, Miura-Yura E, Katanasaka Y, Min KD, Chavkin N, Polizio AH, Ogawa H, Horitani K, Doviak H, Evans MA, Sano M, Wang Y, Boroviak K, Philippos G, Domingues AF, Vassiliou G, Sano S, Walsh K. Yura Y, et al. Circ Res. 2021 Sep 3;129(6):684-698. doi: 10.1161/CIRCRESAHA.121.319314. Epub 2021 Jul 28. Circ Res. 2021. PMID: 34315245 Free PMC article.
[Figure: see text]....
[Figure: see text]....
Ecodesign and Operational Strategies to Reduce the Carbon Footprint of MRI for Energy Cost Savings.
Woolen SA, Becker AE, Martin AJ, Knoerl R, Lam V, Folsom J, Eusemann C, Hess CP, Deshpande V. Woolen SA, et al. Radiology. 2023 May;307(4):e230441. doi: 10.1148/radiol.230441. Epub 2023 Apr 25. Radiology. 2023. PMID: 37097133
Results Projected annual energy consumption per scanner ranged from 82.7 to 171.1 MW-hours, with 72%-91% defined as nonproductive. Power draws for each mode were measured as 6.4 kW 0.1 (SD; power-save mode), 7.3 kW 0.6 to 9.7 kW 0.2 (off), 9.5 kW 0.9 t …
Results Projected annual energy consumption per scanner ranged from 82.7 to 171.1 MW-hours, with 72%-91% defined as nonproductive. Power dra …
140 results